Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study
Expert Review of Clinical Pharmacology · 2025
DOI: 10.1080/17512433.2025.2470834 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Expert Review of Clinical Pharmacology, 2025. Verfasst von Chih-Cheng Lai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. Hauptthemen laut MEDLINE: Asthma, Anti-Asthmatic Agents, Adrenal Cortex Hormones, Glucocorticoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: AstraZeneca Taiwan.
Abstract (Originalsprache)
BACKGROUND: Asthma patients requiring oral corticosteroids (OCS) are at increased risk of adverse effects. Research focusing on asthma patients adhering to guideline-directed therapy remains limited. This study evaluates the adverse effects of corticosteroids in asthma patients treated with high-dose inhaled corticosteroids (ICS) who required additional OCS due to inadequate disease control. RESEARCH DESIGN AND METHODS: We conducted a retrospective cohort study of asthma patients from Taiwan's asthma pay-for-performance program, who had used high-dose ICS for at least 90 days, categorizing them based on OCS use. In the short-term period (3 months), patients were classified into a control group (no OCS) and an OCS group (≥450 mg OCS within 90 days). In the long-term period (6 months), the OCS group consisted of patients receiving ≥ 900 mg OCS within 180 days. RESULTS: A total of 173,835 patients were enrolled for analysis. We assessed the risks of osteoporosis, diabetes, hypertension, infections, cardiovascular diseases, mental health disorders, and ocular conditions. Both short- and long-term OCS users exhibited significantly higher risks of these adverse outcomes compared to the control group. CONCLUSIONS: These findings highlight the substantial health risks associated with OCS. Clinicians should carefully consider alternative strategies to minimize harm while ensuring effective disease control. Asthma is a common condition that affects breathing. People with asthma often need medication to control their symptoms. Some people with severe asthma need drugs called oral corticosteroids (OCS), which help reduce swelling in the airways. However, using OCS for a long time can cause serious side effects. Many studies have looked at these side effects in different groups of people, but not much research has focused on people with asthma specifically.This study looked at how OCS affect people with asthma patients who already use high-dose inhaled corticosteroids (ICS). We studied patients who used ICS for at least 3 months. We split these patients into two groups based on whether they used OCS for a short period (3 months) or a longer period (6 months). We found that people who took OCS were more likely to develop health problems. These problems included: Weak bones (osteoporosis)DiabetesHigh blood pressureInfectionsHeart diseaseAnxiety and depressionCataractsKidney problemsEven taking OCS for a short time increased these risks. The risks were even higher for people who took OCS for a longer time. This research highlights the importance of carefully considering the benefits and risks of OCS in asthma treatment. It is also important to look for other treatments that might be safer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
- School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Taitung MacKay Memorial Hospital, Taitung, Taiwan.
- Department of Medicine, MacKey Medical College, New Taipei City, Taiwan.
- Master of Science in Decision Analysis, Minerva's University, San Francisco, CA, USA.
- Medical Research Center, Cardinal Tien Hospital, and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei, Taiwan.
ORCID-Profile: Chih-Cheng Lai, Chao-Hsien Chen, Cheng-Yi Wang
Förderung
- AstraZeneca Taiwan
Zitieren
APA
Lai, C. C., Chen, C. H., Wang, Y. H., Wang, C. Y., & Wang, H. C. (2025). Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2025.2470834
Vancouver
Lai CC, Chen CH, Wang YH, Wang CY, Wang HC. Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study. Expert Review of Clinical Pharmacology. 2025. doi:10.1080/17512433.2025.2470834
BibTeX
@article{Lai2025,
author = {Lai, Chih-Cheng and Chen, Chao-Hsien and Wang, Ya-Hui and Wang, Cheng-Yi and Wang, Hao-Chien},
title = {Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study},
journal = {Expert Review of Clinical Pharmacology},
year = {2025},
doi = {10.1080/17512433.2025.2470834}
}
EUVIMED